Bloomberg Businessweek Bristol’s $14 Billion Karuna Deal Highlights Race for New Drugs
Dec 22, 2023
Bristol Myers' $14 billion acquisition of Karuna Therapeutics in the race for new drugs. Finding value in the markets explained by CIO at NFJ Investment Group. Priceline CEO talks about a busy holiday travel season. Year in crypto and outlook for 2024. Silicon Valley's quest to live forever. Insights on stock market, investment strategies, and video industry. Travel industry updates and currency market analysis.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11
Introduction
00:00 • 2min
Bristol Myers Squibb's $14 Billion Acquisition of Karuna Therapeutics
01:33 • 9min
Focus on CNS Drug Development and Perspectives on a Big Deal
10:55 • 2min
Rebound in Unloved Market Segments
12:32 • 8min
Strategies for Playing Defense in the Market and Reflection on Contrarian Position
20:38 • 3min
Travel Industry Updates and Holiday Travel Tips
23:53 • 9min
Recent Developments in the Cryptocurrency Sector
33:12 • 8min
The Pursuit of Living Longer and Aging Slower
41:13 • 14min
Introduction, Watson X Code Assistant Ad, The Restless Ones Podcast Ad
55:27 • 3min
Stock Market Analysis and Year in Review
58:01 • 7min
Top Pick for Buying Stocks and Video Industry Insights
01:05:22 • 2min